S.B. Kaye
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer survivorship and care
Papers in
-
- Gastric Cancer Management and Outcomes 2
- Renal cell carcinoma treatment 1
- Surgery 4
- Co-authors
- J. Wanders (4 shared papers)N. Pavlidis (1 shared paper)Patrick Schöffski (1 shared paper)H. R. Franklin (1 shared paper)Thomas Cerny (1 shared paper)Steven Kaplan (1 shared paper)Ron Epelbaum (1 shared paper)M Soukop (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Cancer (2 papers)Advanced Science (1 paper)The Journal of Urology (1 paper)
- Partner nations
- BelgiumUnited KingdomNetherlands
In The Last Decade
S.B. Kaye
13 papers receiving 394 citations
Peers
Comparison fields: 5 of 53
- Reproductive Medicine 108
- Oncology 195
- Pulmonary and Respiratory Medicine 112
- Obstetrics and Gynecology 24
- Dermatology 21
Countries citing papers authored by S.B. Kaye
This map shows the geographic impact of S.B. Kaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.B. Kaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.B. Kaye more than expected).
Fields of papers citing papers by S.B. Kaye
This network shows the impact of papers produced by S.B. Kaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.B. Kaye. The network helps show where S.B. Kaye may publish in the future.
Co-authors
The 25 scholars most cited alongside S.B. Kaye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 145 | |
| 2 | 1995 | 101 | |
| 3 | Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial | 2013 | 75 |
| 4 | 1991 | 49 | |
| 5 | 2011 | 17 | |
| 6 | 1995 | 8 | |
| 7 | 1993 | 3 | |
| 8 | 1993 | 3 | |
| 9 | 1988 | 2 | |
| 10 | 2006 | 2 | |
| 11 | 2011 | 2 | |
| 12 | 1997 | 1 | |
| 13 | 1999 | 1 | |
| 14 | 2025 | 0 |
About S.B. Kaye
S.B. Kaye is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Cancer Research, having authored 14 papers that have together received 409 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Head and Neck Cancer Studies (1 paper), Renal cell carcinoma treatment (1 paper), Urologic and reproductive health conditions (1 paper), Cancer Genomics and Diagnostics (1 paper), Ovarian cancer diagnosis and treatment (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Reproductive Medicine (108 citations), Oncology (195 citations), Pulmonary and Respiratory Medicine (112 citations), Obstetrics and Gynecology (24 citations) and Dermatology (21 citations). S.B. Kaye has collaborated with scholars based in Belgium, United Kingdom and Netherlands. Frequent co-authors include J. Wanders, N. Pavlidis, Patrick Schöffski, H. R. Franklin, Thomas Cerny, Steven Kaplan, Ron Epelbaum, M Soukop, A. van Oosterom and M. Bayssas. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, British Journal of Cancer, Advanced Science and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.